Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2011

01-07-2011 | Erratum

Erratum to: Lymphedema and breast cancer: a review of the literature

Authors: Michael Stamatakos, Charikleia Stefanaki, Konstantinos Kontzoglou

Published in: Breast Cancer | Issue 3/2011

Login to get access

Excerpt

The authors’ names appeared incorrectly in the article cited above. The authors’ names should be correctly shown as follows: …
Metadata
Title
Erratum to: Lymphedema and breast cancer: a review of the literature
Authors
Michael Stamatakos
Charikleia Stefanaki
Konstantinos Kontzoglou
Publication date
01-07-2011
Publisher
Springer Japan
Published in
Breast Cancer / Issue 3/2011
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-011-0283-4

Other articles of this Issue 3/2011

Breast Cancer 3/2011 Go to the issue

Original Article

Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients

Special Feature

Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy

Case Report

A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer

Original Article

Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane

Original Article

Biweekly gemcitabine–paclitaxel, gemcitabine–carboplatin, or gemcitabine–cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial

Special Feature

MR imaging of triple-negative breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits